Entering text into the input field will update the search result below

FDA OKs Boston Scientific's Spectra WaveWriter SCS System

Jan. 11, 2018 7:04 AM ETBoston Scientific Corporation (BSX) StockBy: Douglas W. House, SA News Editor
  • The FDA approves Boston Scientific's (NYSE:BSX) Spectra WaveWriter Spinal Cord Stimulation (SCS) System for the treatment of chronic pain. The company says it is the only approved SCS device that simultaneously provides paresthesia (tingling or numbness)-based and sub-perception therapy enabling patients to customize their pain management therapy.
  • SCS works by sending low electrical pulse of varying frequency, pulse width and amplitude to the spinal cord to interrupt pain signals.

Recommended For You

More Trending News

About BSX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BSX--
Boston Scientific Corporation